German drugmaker Bayer expects to sell some cotton and canola seed businesses to allay antitrust regulator’s concerns about its planned takeover of Monsanto, the head of Bayer’s Crop Science division told German daily Taz. “In North America the combined market share in cotton is indeed quite high. We anticipate that parts of this business may have to be divested,” unit head Liam Condon was quoted as saying on Monday.
“Another strong market position in North America will emerge in canola,” he added.
German drug and crop chemical maker Bayer clinched the $66 billion takeover of US seeds company Monsanto in September, ending months of wrangling. Antitrust experts have said regulators will likely demand the sale of some soybeans, cotton and canola seed assets.
Condon told the newspaper that overall, “there will not be less competition because we hardly have any overlap” with Monsanto, reiterating that antitrust remedies would not pose a serious hurdle to completing the deal.
Full Content: Business Recorder
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
FTC Pushes Review of CoStar’s Commercial Real Estate Antitrust Case
Jan 31, 2024 by
CPI
UK’s CMA Investigates Ardonagh’s Atlanta Group and Markerstudy Merger
Jan 31, 2024 by
CPI
Greenberg Traurig Grow Financial Regulatory and Compliance Practice
Jan 31, 2024 by
CPI
Dutch Regulator Fines Uber €10 Million for Privacy Violations
Jan 31, 2024 by
CPI
DOJ Investigates AI Competition, Eyes Microsoft’s OpenAI Deal: Bloomberg
Jan 31, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – The Rule(s) of Reason
Jan 29, 2024 by
CPI
Evolving the Rule of Reason for Legacy Business Conduct
Jan 29, 2024 by
CPI
The Object Identity
Jan 29, 2024 by
CPI
In Praise of Rules-Based Antitrust
Jan 29, 2024 by
CPI
The Future of State AG Antitrust Enforcement and Federal-State Cooperation
Jan 29, 2024 by
CPI